Centese Funding: How Much Did They Raise & Key Investors

How Much Did Centese Raise?
Funding & Key Investors

Centese has successfully secured a major strategic investment, bringing its total capital accumulation to $15.3M. This latest infusion of $250K underscores the company's pivotal role in modernizing surgical infrastructure. By leveraging this significant financial backing, the organization is well-positioned to accelerate its market penetration and refine its proprietary technology stack within the competitive medical device landscape.

The trajectory of Centese reflects a robust growth narrative, moving from its earlier Series B financing to this current enterprise-level milestone. This capital injection serves as a testament to the firm's ability to deliver measurable improvements in clinical outcomes, effectively bridging the gap between traditional surgical drainage methods and the next generation of intelligent, data-driven healthcare solutions.

What is Centese?

Centese

Manufacturing

Medical Devices & Equipment

Centese specializes in the development of innovative surgical drainage solutions, most notably the Thoraguard system. Designed specifically for the rigors of cardiothoracic surgery, Thoraguard represents a significant departure from legacy drainage systems by integrating precise data monitoring with automated chest tube clearance. This technological advancement directly addresses the critical need for improved patient safety and streamlined workflows in ICU and critical care environments.

By providing clinicians with reliable, real-time data for informed decision-making, Centese is actively reducing recovery times and operational costs for healthcare providers. The company's market position is defined by its commitment to clinical excellence and its ability to solve complex, high-stakes challenges in thoracic surgery through intelligent, reliable engineering.

How much funding has Centese raised?

Centese has raised a total of $15.3M across 2 funding rounds:

2023

Series B

$15M

2026

Private Equity

$250K

Series B (2023): $15M with participation from MedTech Venture Partners

Private Equity (2026): $250K, investors not publicly disclosed

Key Investors in Centese

MedTech Venture Partners

MedTech Venture Partners is a specialized investment firm focused on the medical technology sector, providing strategic guidance and capital to companies advancing healthcare solutions.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Centese?

With the successful closure of this major strategic investment, Centese is poised to scale its operations and expand the reach of the Thoraguard platform. The company's strategic roadmap likely involves deepening its footprint in major hospital networks and investing in further R&D to enhance its data analytics capabilities. As the firm transitions into this mature phase of its lifecycle, the focus will shift toward long-term sustainability and the establishment of new standards in surgical care. The influx of capital provides the necessary runway to navigate regulatory landscapes and solidify its reputation as a leader in the medical technology sector, ultimately driving value for both clinical stakeholders and the broader healthcare ecosystem.

See full Centese company page

See More Financial Insights